A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC
Condition(s):Head and Neck Squamous Cell CarcinomasLast Updated:October 8, 2021Recruiting
Hide Studies Not Open or Pending
Condition(s):Head and Neck Squamous Cell CarcinomasLast Updated:October 8, 2021Recruiting
Condition(s):Stage III NSCLCLast Updated:October 19, 2020Withdrawn
Condition(s):Lung Injury, Acute; Ultrasound Therapy; ComplicationsLast Updated:December 13, 2022Recruiting
Condition(s):Relapsed Mantle Cell Lymphoma; Refractory Mantle Cell LymphomaLast Updated:September 15, 2022Recruiting
Condition(s):Metastatic MelanomaLast Updated:August 29, 2013Completed
Condition(s):Precursor Cell Lymphoblastic Leukemia-Lymphoma; Philadelphia-Positive Acute Lymphoblastic Leukemia; ALL, AdultLast Updated:October 1, 2021Recruiting
Condition(s):Carcinoma, Non-Small Cell LungLast Updated:March 21, 2019Unknown status
Condition(s):Acute Myeloid LeukemiaLast Updated:August 10, 2022Recruiting
Condition(s):Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer; Papillary Serous Mullerian Tumor; Clear Cell Mullerian TumorLast Updated:July 27, 2018Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:November 3, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.